TAVR Found Non-Inferior to SAVR for Low-Risk Patients
Trial bolsters evidence that less invasive strategy is safe and effective in younger, lower-risk patients
Stay updated with breaking news from German Heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Trial bolsters evidence that less invasive strategy is safe and effective in younger, lower-risk patients
Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated with substantial decreased rates of death or stroke at one year in low-risk patients, compared with surgical aortic valve replacement (SAVR), according to findings presented at the American College of Cardiology's Annual Scientific Session.
Underlying heart disease, which may manifest itself in fainting episodes and unexplained accidents, may be responsible for sudden cardiac arrest among youth.
The unprecedented steps taken to accelerate the response to the COVID-19 pandemic could serve as a template for aligning regulatory frameworks with emerging challenges to health systems. That was one of the takeaways from the second national event of the Future-Proofing Medicines initiative staged by Science|Business and EIT Health, via its Germany-Switzerland Regional Innovation Hub, during the KassenGipfel 2022 on 29th September in Berlin.
Those with a heart condition might be tempted to rely on a smartwatch to tell them when something is wrong with their hearts, but there is a limit, warn experts.